Wellington Partners

Wellington Partners

Overview

Wellington Partners is a leading European venture capital firm supporting outstanding entrepreneurs and their products on their way to market leadership. The firm invests in early- and growth-stage life science companies in the fields of biotechnology, therapeutics, medical devices, diagnostics and digital health.

Year Founded

1998

Portfolio Companies

45

Investments

CompanyDateStageLead
NUCLIDIUM AGMay 2026Series B ExtensionLead
SNIPR BiomeAug 2025Series BLead
NUCLIDIUM AGJul 2025Series BLead
AktiiaMay 2025Series BLead
HiloMay 2025Series BLead

Key People

Rainer Strohmenger

Managing Partner

Christian Reitberger

General Partner

Stuart Essig

Venture Partner

Wolfgang Baiker

Venture Partner

Johannes Fischer

Partner

Sabine Kannegiesser

Partner

Varun Gupta

Partner

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersMunich, Bavaria
Year Founded1998

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.